# Veeva Systems Inc. – Consensus ‘buy’ rating and 21.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/veeva-systems-inc.consensus-buy-rating-and-21.7-upside-potential/4121153125
- Published: 2024-04-23T14:10:11+01:00
- Author: Charlotte Edwards

**Veeva Systems Inc.** which can be found using ticker (VEEV) now have 24 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The target
price High/Low ranges between $270.00 and $200.00 suggesting an average Analsyt 
target price of $241.47. Now with the previous closing price of $198.38 this now
indicates there is a potential upside of 21.7%. The 50 day MA is $220.49 and the
200 day MA is $202.44. The market cap for the company is 32.11B. The stock price
is currently at: $199.06 USD

 The potential market cap would be $39,086,735,219 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 61.82, revenue per share of $14.72
and a 5.01% return on assets.

Veeva Systems Inc. is a provider of industry cloud solutions for the global life
sciences industry. The Company’s offerings span cloud software, data, and business
consulting and are designed to meet the needs of its customers and their most strategic
business functions from research and development (R&D) to commercialization. The
Company’s industry cloud solutions for the life sciences industry are grouped into
two major product families: Veeva Development Cloud and Veeva Commercial Cloud. 
Veeva Development Cloud includes application suites for the clinical, regulatory,
and safety functions of life sciences companies, all built on its proprietary Veeva
Vault platform. Veeva Commercial Cloud includes solutions for the sales, medical
affairs, and marketing functions of a life sciences company. Its software offerings
include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix.
Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Share on: